首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Future Medicinal Chemistry

Future Medicinal Chemistry杂志,由Future Science出版,于2009年创刊,Monthly,出版语言English,ISSN:1756-8919,E-ISSN:1756-8927。

投稿咨询
Future Medicinal Chemistry
Future Medicinal Chemistry
Future Medicinal Chemistry
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
3.3
CiteScore
4.4
期刊收录
SCI、SCIE

Future Medicinal Chemistry(中文译名:《未来药物化学》),ISSN:1756-8919,EISSN:1756-8927,是Future Science出版的国际性学术期刊,创刊于2009年,以Monthly形式稳定发行,2026年总发文量约189篇。该刊采用非OA开放访问,学科归属为CHEMISTRY, MEDICINAL。该刊是医学、药物化学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.3,2025年期刊CiteScore为4.4,2025年期刊自引率约3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Future Medicinal Chemistry长期聚焦医学、药物化学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药物化学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Italy、India、Egypt、Spain、England等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CHEMISTRY, MEDICINAL 药物化学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 41 / 72

43.8

学科:CHEMISTRY, MEDICINAL SCIE Q3 42 / 72

42.36

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 36 / 72

50.7

学科:CHEMISTRY, MEDICINAL SCIE Q3 42 / 72

42.36


中国学者近期发文

1
Modulating human IAPP aggregation in type 2 diabetes: inhibitors, mechanisms, and translational challenge

Author:Shi, Kaiwen; Jin, Jia; Zhang, Kui; Guo, Siqi; Ye, Fei

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. 18, Issue 8, pp. 979-991. DOI: 10.1080/17568919.2026.2636492

2
Discovery of novel 2,4-diarylaminopyrimidine derivatives as FAK inhibitors with potent anti-cancer potenc

Author:Lv, Yu-Zheng; Song, Jian; Zhang, Sai-Yang; Xu, Yan; Xi, Shou-Min

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2648996

3
Synergistic action of JNK activation and BChE inhibition: a novel anti- glioblastoma compound with neuroprotective profil

Author:Lu, Ziyao; Liao, Qinghong; Duan, Yuetong; Wang, Kaixuan; He, Siyu; Lyu, Weiping; Chen, Xuehong; Li, Qi

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2658833

4
Cyclization, amino acid coupling, docking-based virtual screening and SAR: showing a strategy of the structural modification for salvianic acid

Author:Wu, Jianhui; Zhang, Xiaoyi; An, Wenshuo; Yang, Yifan; Zhang, Peiwen; Wang, Yaonan; Zhao, Shurui; Feng, Qiqi; Zhao, Ming; Peng, Shiqi

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2658836

5
Overview of recent strategic advances in antiviral covalent inhibitor

Author:Wang, Bo; Wang, Siyuan; Zhang, Jiwei; Kim, Meehyein; Zhan, Peng

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642579

6
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activit

Author:Li, Xuhong; Liang, Yan; Zhang, Xiaoyu; Wu, Yongsheng; Wu, Tizhi; Tian, Yucheng; Tang, Cheng; Qiu, Zhixia; Wu, Hongxi; Bian, Jinlei; Li, Zhiyu; Xu, Xi; Wang, Jubo

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642584

7
Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitor

Author:Shao, Wu-Bin; Zhou, Xiang; Yang, Song; Zhou, Ying

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642580

8
Recent advances in the design and development of small molecules targeting the TLR4 signaling pathwa

Author:Ishfaq, Muhammad; Shahab, Muhammad; Jiang, Guosong

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2648983

9
Design, synthesis and antitumor activity evaluation of 1,4-naphthoquinone-benzene sulfonamide hybrid

Author:Wei, Gang; Fan, Zi-Han; Huang, Ri-Zhen; Wei, Yi; Lei, Yu-Ban; Zhang, Bao-Qi; Tang, Yan; Luo, Li; Wang, Heng-Shan; Jiang, Jing-Chen; Li, Mei-Shan

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2628558

10
Targeting the cGAS-STING-TBK1 pathway in cancer therap

Author:Jiang, Leyao; Zhong, Ying; Zhang, Zilong; Yang, Qichen; Sun, Shengting; Sun, Huiqi; Liu, Zongliang

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2628553


在线咨询

Future Medicinal Chemistry

国际简称:FUTURE MED CHEM参考译名:未来药物化学

年发文量:189 CiteScore:4.4 是否预警:否 Gold OA文章占比:2.30% 研究类文章占比:60.32%

杂志社联系方式:FUTURE SCI LTD, UNITED HOUSE, 2 ALBERT PL, LONDON, ENGLAND, N3 1QB

Future Medicinal Chemistry